Neoadjuvant Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor

NCT07171203 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Stromal Tumors

Interventions

DRUG: Imatinib
DRUG: Fampridine

Sponsor

University of California, San Diego